Compare Amphastar Pharmaceuticals Inc (AMPH) vs Super Micro Computer Inc (SMCI) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Super Micro Computer (SMCI) trades at $31.13, up 5.96% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamental metrics with a P/E of 16.56 and P/S of 0.62, while recent earnings have beaten expectations. Revenue growth remains robust, reaching $21.97B in 2025, though net margins compressed to 3.7%. Analyst consensus is mixed with a $39.20 price target, representing 26% upside potential from current levels.

The outlook for SMCI hinges on execution of its massive $60B AI server order backlog and margin expansion to 15-17% guidance. Key risks include working capital strain with negative operating cash flow projected for 2026 and high dependence on Nvidia components. While valuation appears attractive, investors should monitor the company's ability to convert orders into profitable growth amid intense AI infrastructure competition.